1-12 of 12
Keywords: Intravenous immunoglobulin
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Eur Neurol (2019) 80 (5-6): 304–310.
Published Online: 19 March 2019
...Jill R. Schofield; Kamal R. Chemali Intravenous immunoglobulin therapy is FDA approved for the immune-mediated peripheral nerve disorders Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy. Immunoglobulin therapy has been used increasingly...
Journal Articles
Eur Neurol (2016) 76 (3-4): 182–186.
Published Online: 27 September 2016
... immunoglobulin Thromboembolism Guillain-Barré syndrome (GBS) is an acute inflammatory demyelinating neuropathy typically following a mild respiratory or gastrointestinal viral infection. Intravenous immunoglobulin (IVIg) is used as an effective and safe treatment for GBS, but its severe complications...
Journal Articles
Eur Neurol (2016) 75 (3-4): 199–206.
Published Online: 15 April 2016
..., instructions or products referred to in the content or advertisements. Anxiety/depression Fatigue Immune-mediated polyneuropathies Intravenous immunoglobulin Pain Strength and sensory deficits dominate the clinical picture and outcome assessments in clinical trials of patients...
Journal Articles
Eur Neurol (2014) 71 (1-2): 89–92.
Published Online: 05 December 2013
... of glucocorticoids, immunosuppressants, acetyl salicylic acid, and immunomodulatory agents such as intravenous immunoglobulin. Methods: We present the case histories of 2 young women with Susac syndrome presenting with several episodes of encephalopathy, branch retinal artery occlusions, and hearing loss that were...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Eur Neurol (2005) 53 (2): 64–67.
Published Online: 23 May 2005
... for immunoglobulin G (IgG), high-dose intravenous immunoglobulin (IVIg) may interfere with CD16+CD57– NK cells via Fc receptor blockade. In addition, cyclophosphamide (Cy) is often used to suppress NK cells. Therefore, our findings may partly account for the effectiveness of IVIg or Cy, which is the current...
Journal Articles
Journal Articles
Eur Neurol (2004) 52 (3): 141–144.
Published Online: 19 November 2004
...S. Vucic; P. Siao Tick Chong; K.T. Dawson; M. Cudkowicz; D. Cros Intravenous immunoglobulin (IVIg) preparations are increasingly being used in the treatment of neuroautoimmune diseases. Although for most part this treatment is safe, serious side effects such as thromboembolic events have been...
Journal Articles
Journal Articles
Eur Neurol (1998) 39 (1): 3–8.
Published Online: 09 January 1998
...A.J. Wills; D.J. Unsworth Intravenous immunoglobulin is now used in a wide range of neurological conditions. However, side effects are relatively common, treatment is expensive and sustained benefit unusual without repeated administration. This article aims to provide clinicians with an overview...